130 related articles for article (PubMed ID: 3117375)
1. Identification, isolation, and characterization of a novel cytotoxin in murine cytolytic lymphocytes.
Liu CC; Steffen M; King F; Young JD
Cell; 1987 Nov; 51(3):393-403. PubMed ID: 3117375
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin.
Liu CC; Detmers PA; Jiang SB; Young JD
Proc Natl Acad Sci U S A; 1989 May; 86(9):3286-90. PubMed ID: 2654942
[TBL] [Abstract][Full Text] [Related]
4. Production of lymphotoxin and tumour necrosis factor by a T-cell hybridoma.
Kobayashi Y; Asada M; Osawa T
Immunology; 1987 Feb; 60(2):213-7. PubMed ID: 3102354
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. I. Cytotoxins produced by antigen-specific and natural killer-like CTL are dissimilar to classical lymphotoxins.
Green LM; Stern ML; Haviland DL; Mills BJ; Ware CF
J Immunol; 1985 Dec; 135(6):4034-43. PubMed ID: 2415596
[TBL] [Abstract][Full Text] [Related]
6. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
8. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
Kuwano K; Akashi A; Arai S
Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
Garner R; Helgason CD; Atkinson EA; Pinkoski MJ; Ostergaard HL; Sorensen O; Fu A; Lapchak PH; Rabinovitch A; McElhaney JE
J Immunol; 1994 Dec; 153(12):5413-21. PubMed ID: 7527440
[TBL] [Abstract][Full Text] [Related]
10. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity.
Blakely A; Gorman K; Ostergaard H; Svoboda K; Liu CC; Young JD; Clark WR
J Exp Med; 1987 Oct; 166(4):1070-83. PubMed ID: 3498787
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
12. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
[TBL] [Abstract][Full Text] [Related]
13. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor.
Young JD; Liu CC; Butler G; Cohn ZA; Galli SJ
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9175-9. PubMed ID: 3321069
[TBL] [Abstract][Full Text] [Related]
14. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
Hommel-Berrey G; Bochan M; Brahmi Z
Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
[TBL] [Abstract][Full Text] [Related]
15. The role of the Fas lytic pathway in a perforin-less CTL hybridoma.
Walsh CM; Glass AA; Chiu V; Clark WR
J Immunol; 1994 Sep; 153(6):2506-14. PubMed ID: 7521365
[TBL] [Abstract][Full Text] [Related]
16. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.
Sung SS; Bjorndahl JM; Wang CY; Kao HT; Fu SM
J Exp Med; 1988 Mar; 167(3):937-53. PubMed ID: 2965212
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a serine esterase from cytolytic T cell granules.
Young JD; Leong LG; Liu CC; Damiano A; Wall DA; Cohn ZA
Cell; 1986 Oct; 47(2):183-94. PubMed ID: 3094960
[TBL] [Abstract][Full Text] [Related]
18. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes.
Young JD; Clark WR; Liu CC; Cohn ZA
J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267
[TBL] [Abstract][Full Text] [Related]
19. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
20. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
